澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

IMRICOR MEDICAL SYSTEMS-CDI

1.970

+0.0301.55%

成交量：34.28万

成交额：68.03万

市值：6.32亿

市盈率：-16.52

高：2.020

开：1.960

低：1.950

收：1.940

52周最高：2.250

52周最低：1.115

股本：3.21亿

流通股本：2.75亿

量比：0.51

换手率：0.12%

股息：- -

股息率：- -

每股收益(TTM):-0.119

每股收益(LYR):-0.119

净资产收益率：-1221.27%

总资产收益率：-42.28%

市净率：37.73

市盈率(LYR):-16.52

数据加载中...

总览公司新闻资讯公告

IMRICOR MEDICAL SYSTEMS-CDI - UVA健康获得机构审查委员会批准，参与公司的Visabl-Afl临床试验

Imricor Medical Systems Inc成功完成FDA审批通道内所有设备的人因工程研究

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/IMR.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","market":"AU","secType":"STK","nameCN":"IMRICOR MEDICAL SYSTEMS-CDI","latestPrice":1.97,"timestamp":1774501920000,"preClose":1.94,"halted":0,"volume":342838,"delay":0,"changeRate":0.01546391752577321,"nameEN":"IMRICOR MEDICAL SYSTEMS-CDI","floatShares":275046474,"shares":320947028,"eps":-0.11923893445006689,"marketStatus":"未开盘","change":0.03,"latestTime":"03-26 16:12:00 AEDT","open":1.96,"high":2.02,"low":1.95,"amount":680277,"amplitude":0.036082,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.11923893445006689,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1774566000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":1.94,"openAndCloseTimeList":[[1774479600000,1774501200000]],"volumeRatio":0.5083013852810696,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMR.AU","preClose":1.97,"auctionPrice":1.97,"auctionVolume":13088,"auctionTime":1774555506463,"referenceTime":1774517404089,"auction":1,"marketStatus":"盘前竞价","timestamp":1774555506463}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","floatShares":275046474,"roa":"-42.28%","roe":"-1221.27%","lyrEps":-0.119239,"volumeRatio":0.5083013852810696,"shares":320947028,"dividePrice":0,"high":2.02,"amplitude":0.036082,"preClose":1.94,"low":1.95,"week52Low":1.115,"pbRate":"37.73","psRate":"1487.54","week52High":2.25,"institutionHeld":0,"latestPrice":1.97,"eps":-0.11923893445006689,"divideRate":0,"volume":342838,"delay":0,"ttmEps":-0.11923893445006689,"open":1.96,"prevYearClose":1.53,"prevWeekClose":1.95,"prevMonthClose":2.15,"prevQuarterClose":1.53,"fiveDayClose":1.82,"twentyDayClose":2.06,"sixtyDayClose":1.477,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMR.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-24","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771887600000,"name":null,"time":"","dateTimestamp":1771851600000,"actualEps":null},{"date":"2025-08-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756166400000,"name":null,"time":"","dateTimestamp":1756130400000,"actualEps":null},{"date":"2025-02-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-28","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724803200000,"name":null,"time":"","dateTimestamp":1724767200000,"actualEps":null},{"date":"2024-04-30","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1714435200000,"name":null,"time":"","dateTimestamp":1714399200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMR.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1104146213","title":"IMRICOR MEDICAL SYSTEMS-CDI - UVA健康获得机构审查委员会批准，参与公司的Visabl-Afl临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1104146213","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104146213?lang=zh_cn&edition=fundamental","pubTime":"2025-12-15 05:26","pubTimestamp":1765747570,"startTime":"0","endTime":"0","summary":"IMRICOR MEDICAL SYSTEMS-CDI - UVA健康获得机构审查委员会批准，参与公司的Visabl-Afl临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","BK7007","BK7508","IMR.AU"],"gpt_icon":0},{"id":"1199473456","title":"Imricor Medical Systems Inc成功完成FDA审批通道内所有设备的人因工程研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1199473456","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199473456?lang=zh_cn&edition=fundamental","pubTime":"2025-09-18 06:55","pubTimestamp":1758149714,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems Inc宣布已成功完成其FDA审批通道内所有医疗设备的人因工程研究。\n该项研究的顺利完成标志着公司在获得美国食品药品监督管理局(FDA)批准方面迈出了重要一步，为其医疗设备产品的商业化进程奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","IMR.AU","BK7007","BK7508"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}